ArticleScientific reports2025
Development and validation of a Japanese version of the multimorbidity treatment burden questionnaire.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Physician Characteristics Associated with Prioritizing Treatment Burden in Outpatient Care for Older Adults with Multimorbidity.JMA journal · 2026Article
- Lingering Effects on the Ecology of Medical Care After the COVID-19 Pandemic: A Nationwide Repeated Cross-Sectional Study in Japan.Journal of general and family medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aimed to develop a Japanese version of the Multimorbidity Treatment Burden Questionnaire (J-MTBQ) and examine its validity and reliability. The MTBQ was translated into Japanese using forward and backward translation and cognitive interviews assessed content validity in a Japanese context. We conducted a nationwide postal survey using a representative panel of the Japanese adult population. Eligible participants in this study were patients with multimorbidity (≥ 2 long-term conditions). Structural validity, convergent validity, known-groups validity, and internal consistency reliability were assessed. Cognitive interviews found good acceptability and content validity. The survey was completed by 383 patients. Confirmatory factor analysis supported the scale's structural validity and a one-factor solution. In hypothesis testing, the J-MTBQ score had a negative association with health-related quality of life and self-rated health; and a positive association with the number of long-term conditions and prescribed medications. Cronbach's alpha indicated a high level of internal consistency reliability. We have developed a J-MTBQ and examined its validity and reliability. This scale can be used to identify patients experiencing high treatment burden, to improve the quality of care for patients with multimorbidity, and to assess the impact of interventions for multimorbidity in Japanese-speaking adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.